Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Two different regulatory T cell populations that promote corneal allograft survival.

Cunnusamy K, Paunicka K, Reyes N, Yang W, Chen PW, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6566-74. doi: 10.1167/iovs.10-6161. Epub 2010 Aug 11.

2.

Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells.

Paunicka K, Chen PW, Niederkorn JY.

J Leukoc Biol. 2012 Mar;91(3):475-83. doi: 10.1189/jlb.0311173. Epub 2011 Dec 16.

3.

Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.

Niederkorn JY, Mayhew E, Mellon J, Hegde S.

Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2674-81.

PMID:
15277491
4.

Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.

Skelsey ME, Mellon J, Niederkorn JY.

J Immunol. 2001 Apr 1;166(7):4327-33.

5.
6.

Anterior chamber-associated immune deviation promotes corneal allograft survival.

Niederkorn JY, Mellon J.

Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2700-7.

PMID:
8977485
7.

Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.

Yamada J, Streilein JW.

Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2833-43.

PMID:
9418737
8.

Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes.

Sano Y, Okamoto S, Streilein JW.

Curr Eye Res. 1997 Nov;16(11):1171-4.

PMID:
9395779
10.

CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.

Zhu X, Yang P, Zhou H, Li B, Huang X, Meng Q, Wang L, Kijlstra A.

Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1549-57. Epub 2007 May 31.

PMID:
17541623
11.
12.

The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens.

Saban DR, Cornelius J, Masli S, Schwartzkopff J, Doyle M, Chauhan SK, Peck AB, Grant MB.

Mol Vis. 2008;14:2435-42. Epub 2008 Dec 19.

13.

Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.

Li XY, D'Orazio LT, Niederkorn JY.

Immunology. 1996 Sep;89(1):34-40.

14.

Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.

Yamada J, Kurimoto I, Streilein JW.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2614-21.

PMID:
10509657
15.

IFN-γ blocks CD4+CD25+ Tregs and abolishes immune privilege of minor histocompatibility mismatched corneal allografts.

Cunnusamy K, Niederkorn JY.

Am J Transplant. 2013 Dec;13(12):3076-84. doi: 10.1111/ajt.12466. Epub 2013 Oct 1.

16.

IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts.

Cunnusamy K, Chen PW, Niederkorn JY.

J Immunol. 2011 Jun 15;186(12):6737-45. doi: 10.4049/jimmunol.1100101. Epub 2011 May 6.

17.

Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.

Zhang Y, Zhang M, Zhao S, Li X, Jia Z, Zhang L, Han ZC, Zhang X.

Int Immunopharmacol. 2013 Jan;15(1):114-20. doi: 10.1016/j.intimp.2012.11.007. Epub 2012 Nov 21.

PMID:
23178576
18.

Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.

Reyes NJ, Chen PW, Niederkorn JY.

Am J Transplant. 2013 May;13(5):1181-92. doi: 10.1111/ajt.12198. Epub 2013 Mar 13.

19.

Latanoprost does not affect immune privilege of corneal allografts.

Wang M, Kitahara Y, Yoshida A, Hori J.

Exp Eye Res. 2008 Feb;86(2):394-402. doi: 10.1016/j.exer.2007.11.012. Epub 2007 Nov 28.

PMID:
18187130
20.

Effect of Corneal Nerve Ablation on Immune Tolerance Induced by Corneal Allografts, Oral Immunization, or Anterior Chamber Injection of Antigens.

Mo J, Neelam S, Mellon J, Brown JR, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):137-148. doi: 10.1167/iovs.16-20601.

Supplemental Content

Support Center